• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BIND Therapeutics Inc

+ Add to Watchlist

BIND:US

9.5800 USD 0.0200 0.21%

As of 20:10:00 ET on 04/17/2014.

Snapshot for BIND Therapeutics Inc (BIND)

Open: 9.7500 Day's Range: 9.4000 - 9.9190 Volume: 125,026
Previous Close: 9.5600 52wk Range: 8.3600 - 15.8900 1-Yr Rtn: -

Stock Chart for BIND

No chart data available.
  • BIND:US 9.5800
  • 1D
  • 1M
  • 1Y
9.5600
Interactive BIND Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIND

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.7470
Est. PEG Ratio -
Market Cap (M USD) 157.51
Shares Outstanding (M) 16.44
30 Day Average Volume 137,191
Price/Book (mrq) 2.1336
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIND

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BIND

BIND Therapeutics Inc researches and produces biopharmaceutical products. The Company develops selective targeted and programmable therapeutics to maximize active pharmaceutical ingredients concentrations in diseased tissues. BIND Biosciences serves patients worldwide.

Scott MinickPresident/CEOAndrew J HirschCFO/COO
James Wright "Jim"Chief Scientific OfficerJeff HrkachChief Technology Officer
More Company Profile & Key Executives for BIND

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil